ABPI response to quarantine measures

The Government has today published new guidance on a system of quarantine for people coming into the UK, aimed at preventing transmission of COVID-19.

From 8th June people arriving in the UK must self-isolate for 14 days, subject to some exemptions

The exemptions attached to today’s quarantine measures recognise a number of critical roles for medicine supply and for the continued R&D effort to find COVID-19 vaccines and treatments and will support our members.   Dr Richard Torbett, Chief Executive, ABPI

In response to today's announcement, ABPI Chief Executive Richard Torbett said:

“The exemptions attached to today’s quarantine measures recognise a number of critical roles for medicine supply and for the continued R&D effort to find COVID-19 vaccines and treatments and will support our members.

"Pharmaceutical companies are global, and require fast access to the best talent around the world. We will work closely with Government over the coming weeks to ensure that these plans support our members to carry out this work as effectively as possible.” 

TAGS
  • COVID 19

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.